| Early use of corticosteroids following CAR T-cell therapy correlates with reduced risk of high-grade CRS without negative impact on neurotoxicity or treatment outcome T Lakomy, D Akhoundova, H Nilius, MN Kronig, U Novak, M Daskalakis, ... Biomolecules 13 (2), 382, 2023 | 45 | 2023 |
| Comparative effectiveness and safety of anticoagulants for the treatment of heparin‐induced thrombocytopenia H Nilius, J Kaufmann, A Cuker, M Nagler American journal of hematology 96 (7), 805-815, 2021 | 36 | 2021 |
| Current knowledge on factor V Leiden mutation as a risk factor for recurrent venous thromboembolism: a systematic review and meta-analysis D Eppenberger, H Nilius, B Anagnostelis, CA Huber, M Nagler Frontiers in cardiovascular medicine 9, 883986, 2022 | 18 | 2022 |
| A machine-learning model for reducing misdiagnosis in heparin-induced thrombocytopenia: A prospective, multicenter, observational study H Nilius, A Cuker, S Haug, C Nakas, JD Studt, DA Tsakiris, A Greinacher, ... EClinicalMedicine 55, 2023 | 16 | 2023 |
| Long-term survival after venous thromboembolism: a prospective cohort study H Nilius, T Mertins, R Boss, M Knuchel, E Blozik, JA Kremer Hovinga, ... Frontiers in cardiovascular medicine 8, 749342, 2021 | 6 | 2021 |
| Long-term safety of the stem cell releasing compound plerixafor for peripheral stem cell collection in myeloma patients. M Maechler, VU Bacher, M Daskalakis, HJJ Nilius, M Nagler, ... Hematological oncology 41 (3), 583-586, 2023 | 5 | 2023 |
| Low-Frequency PPM1D Gene Mutations Affect Treatment Response to CD19-Targeted CAR T-Cell Therapy in Large B-Cell Lymphoma K Seipel, M Frey, H Nilius, D Akhoundova, Y Banz, U Bacher, T Pabst Current Oncology 30 (12), 10463-10476, 2023 | 4 | 2023 |
| Image-derived mean velocity measurement for prediction of coronary flow reserve in a canonical stenosis phantom using magnetic particle imaging R Siepmann, H Nilius, F Mueller, K Mueller, C Luisi, SM Dadfar, M Straub, ... Plos one 16 (4), e0249697, 2021 | 4 | 2021 |
| Accuracy of Diagnosing Heparin-Induced Thrombocytopenia EL Larsen, H Nilius, JD Studt, DA Tsakiris, A Greinacher, A Mendez, ... JAMA network open 7 (3), e243786-e243786, 2024 | 3 | 2024 |
| Clinical impact of single nucleotide polymorphism in CD-19 on treatment outcome in FMC63-CAR-T cell therapy K Seipel, M Abbühl, U Bacher, H Nilius, M Daskalakis, T Pabst Cancers 15 (11), 3058, 2023 | 3 | 2023 |
| Secondary prevention of venous thromboembolism: predictors and outcomes of guideline adherence in a long-term prospective cohort study T Mertins, H Nilius, R Boss, M Knuchel, A Signorell, CA Huber, E Blozik, ... Frontiers in cardiovascular medicine 9, 963528, 2022 | 3 | 2022 |
| Prognostic significance of lymph nodes assessment during pulmonary metastasectomy: a systematic review and meta-analysis F Minervini, A Li, M Qu, H Nilius, Y Shargall Journal of thoracic disease 15 (12), 6447, 2023 | 2 | 2023 |
| Next‐generation diagnostic instruments in haematology M Nagler, H Nilius British journal of haematology 202 (5), 925-927, 2023 | 2 | 2023 |
| Limited concordance of heparin/platelet factor 4 antibody assays for the diagnosis of heparin-induced thrombocytopenia: an analysis of the TORADI-HIT study A Hammerer-Lercher, H Nilius, JD Studt, DA Tsakiris, A Greinacher, ... Journal of Thrombosis and Haemostasis 21 (9), 2559-2568, 2023 | 2 | 2023 |
| Machine learning applications in precision medicine: overcoming challenges and unlocking potential H Nilius, S Tsouka, M Nagler, M Masoodi TrAC Trends in Analytical Chemistry, 117872, 2024 | 1 | 2024 |
| Role of intrapulmonary lymph nodes in patients with NSCLC and visceral pleural invasion. The VPI 1314 multicenter registry study protocol F Minervini, P Kestenholz, P Bertoglio, A Li, H Nilius Plos one 18 (5), e0285184, 2023 | 1 | 2023 |
| Towards quantitative Flow Characterization of Fluids using Magnetic Particle Imaging R Siepmann, H Nilius, M Straub, SM Dadfar, M Darguzyte, V Schulz International Workshop on Magnetic Particle Imaging (8th IWMPI), 2018 | 1 | 2018 |
| Comparing stem cell mobilization with chemotherapy and cytokine (G-CSF) versus cytokine alone in myeloma patients (MOCCCA): a randomized phase II, open-label, non-inferiority trial B Jeker, L Thalmann, U Bacher, H Nilius, G Rhyner, M Sökler, ... Bone Marrow Transplantation, 1-7, 2024 | | 2024 |
| Machine-Learning Applications in Thrombosis and Hemostasis H Nilius, M Nagler Hämostaseologie, 2024 | | 2024 |
| Gender-Specific Prognostic Impact of Treosulfan Levels in High-Dose Chemotherapy for Multiple Myeloma AD Heini, K Kammermann, U Bacher, B Jeker, M Hayoz, Y Aebi, ... Cancers 16 (19), 3364, 2024 | | 2024 |
